Abstract: A smoking article filter includes a recess to receive a filter insert unit. The filter insert unit is secured to the filter once inserted. The filter and the filter insert unit may include additives such as flavourants, colourants or sorbents.

Abstract: A smoking article filter includes a recess to receive a filter insert unit. The filter insert unit is secured to the filter once inserted. The filter and the filter insert unit may include additives such as flavourants, colourants or sorbents.

Abstract: A smoking article filter includes a recess to receive a filter insert unit. The filter insert unit is secured to the filter once inserted. The filter and the filter insert unit may include additives such as flavourants, colourants or sorbents.

Abstract: A smoking article filter includes a recess to receive a filter insert unit. The filter insert unit is secured to the filter once inserted. The filter and the filter insert unit may include additives such as flavourants, colourants or sorbents.

Abstract: A smoking article filter (20) comprises a recess (25) to receive a filter insert unit (30). The filter insert unit (30) is secured to the filter (20) once inserted. The filter (20) and the filter insert unit (30) may comprise additives such as flavourants, colourants or sorbents.

Abstract: Embodiments include nonvolatile a memory (NVM) device that can be configured for logic switching and/or digital computing. For example, embodiments of the NVM device can be configured as any one or combination of a memory cell, a D flip flop (DFF), a Backup and Restore circuit (B&R circuit), and/or a latch for a DFF. Any of the NVM devices can have a Fe field effect transistors (FeFET) configured to exploit the IDS?VG hysteresis of the steep switch at low voltage for logic memory synergy. The FeFET-based devices can be configured to include a wide hysteresis, a steep hysteresis edge, and high ratio between the two IDS states at VG=0.

Abstract: Embodiments include nonvolatile a memory (NVM) device that can be configured for logic switching and/or digital computing. For example, embodiments of the NVM device can be configured as any one or combination of a memory cell, a D flip flop (DFF), a Backup and Restore circuit (B&R circuit), and/or a latch for a DFF. Any of the NVM devices can have a Fe field effect transistors (FeFET) configured to exploit the IDS?VG hysteresis of the steep switch at low voltage for logic memory synergy. The FeFET-based devices can be configured to include a wide hysteresis, a steep hysteresis edge, and high ratio between the two IDS states at VG=0.

Abstract: An inhalation device to hold an inhalant-generating component to generate an inhalant to be drawn through the device and inhaled by a user. The device has a body (10) having a first open end (11b) configured to receive an inhalant-generating component and, a second open end (11a) in fluid communication with the first end through which a user may draw inhalant from the inhalant-generating component. The body is configured to receive a flavour delivery component (63) having an organoleptic material to selectively allow or prevent addition of an organoleptic additive into an inhalant stream drawn through the device. The device includes a ventilation control mechanism (15) configured to selectively allow different amounts of ambient air into the body to mix with and dilute the inhalant stream as it is drawn through the device in use.

Abstract: Embodiments include nonvolatile a memory (NVM) device that can be configured for logic switching and/or digital computing. For example, embodiments of the NVM device can be configured as any one or combination of a memory cell, a D flip flop (DFF), a Backup and Restore circuit (B&R circuit), and/or a latch for a DFF. Any of the NVM devices can have a Fe field effect transistors (FeFET) configured to exploit the IDS-VG hysteresis of the steep switch at low voltage for logic memory synergy. The FeFET-based devices can be configured to include a wide hysteresis, a steep hysteresis edge, and high ratio between the two IDS states at VG=0.

Abstract: The present invention relates to improvements in filters for use in smoking articles such as cigarettes, cigars and cigarillos. The improvements, particularly but not exclusively, relate to filter capabilities and to the manufacture of such filters. In one example, a filter for a smoking article comprises a first fibrous filter material having an average fiber denier in the range 7 to 9 and a second fibrous filter material having an average fiber denier of below 7. The application also describes a filter for a smoking article comprising various other filter arrangements including absorbent and/or adsorbent materials.

Abstract: We have constructed a polynucleotide encoding a bispecific antibody engaging molecule which has one arm that specifically engages a tumor cell which expresses the human EGFRvIII mutant protein on its surface, and a second arm that specifically engages T cell activation ligand CD3. The polynucleotide is codon optimized for expression in CHO cells. The subunits of the engaging molecules are organized to achieve greater efficiency. These are promising therapeutic agents.

Abstract: Embodiments include nonvolatile a memory (NVM) device that can be configured for logic switching and/or digital computing. For example, embodiments of the NVM device can be configured as any one or combination of a memory cell, a D flip flop (DFF), a Backup and Restore circuit (B&R circuit), and/or a latch for a DFF. Any of the NVM devices can have a Fe field effect transistors (FeFET) configured to exploit the IDS?VG hysteresis of the steep switch at low voltage for logic memory synergy. The FeFET-based devices can be configured to include a wide hysteresis, a steep hysteresis edge, and high ratio between the two IDS states at VG=0.

Abstract: We have constructed a polynucleotide encoding a bispecific antibody engaging molecule which has one arm that specifically engages a tumor cell which expresses the human EGFRvIII mutant protein on its surface, and a second arm that specifically engages T cell activation ligand CD3. The polynucleotide is codon optimized for expression in CHO cells. The subunits of the engaging molecules are organized to achieve greater efficiency. These are therapeutic agents.

Abstract: We have constructed bispecific antibody engaging molecules which have one arm that specifically engages a tumor cell which expresses the human EGFRvIII mutant protein on its surface, and a second arm that specifically engages T cell activation ligand CD3. The engaging molecules are highly cytotoxic and antigen-specific. These may be used as therapeutic agents.

Abstract: The present invention relates to filter material for inclusion in a smoking article, wherein the filter material is in the form of a fibrous tow or a non-woven sheet comprising fine cellulose acetate fibres having a mean diameter of from about 1 ?m to about 15 um. The invention also relates to processes for preparing filter material for inclusion in a smoking article, the filter material comprising fine cellulose acetate fibres having a mean diameter of from about 1 ?m to about 15 ?m. The invention further relates to filters or filter elements comprising the filter material, smoking articles comprising the same, and use of the filter material in smoke filtration.

Abstract: The present invention relates to improvements in filters for use in smoking articles such as cigarettes, cigars and cigarillos. The improvements, particularly but not exclusively, relate to filter capabilities and to the manufacture of such filters. In one example, a filter for a smoking article comprises a first fibrous filter material having an average fibre denier in the range 7 to 9 and a second fibrous filter material having an average fibre denier of below 7. The application also describes a filter for a smoking article comprising various other filter arrangements including absorbent and/or adsorbent materials.

Abstract: The present invention relates to improvements in filters for use in smoking articles such as cigarettes, cigars and cigarillos. The improvements, particularly but not exclusively, relate to filter capabilities and to the manufacture of such filters. In one example, a filter for a smoking article comprises a first fibrous filter material having an average fibre denier in the range 7 to 9 and a second fibrous filter material having an average fibre denier of below 7. The application also describes a filter for a smoking article comprising various other filter arrangements including absorbent and/or adsorbent materials.

Abstract: We have constructed a polynucleotide encoding a bispecific antibody engaging molecule which has one arm that specifically engages a tumor cell which expresses the human EGFRvIII mutant protein on its surface, and a second arm that specifically engages T cell activation ligand CD3. The polynucleotide is codon optimized for expression in CHO cells. The subunits of the engaging molecules are organized to achieve greater efficiency. These are promising therapeutic agents.

Abstract: A system and method are directed towards enabling centralized registration for managing a selective display of visitor information to distributed social networking websites. A visitor may enter selective personal information, and determine what information is made available on a social networking webpage. The visitor may then return to the social networking website to view selective visitor information, such as within a reader roll. A visitor to a social networking website may select to not have their information displayed at selective a social networking website, while still being displayed at another social networking website. In one embodiment, selecting to not display their information may be performed by ‘mousing’ over their information and selecting a display option. Social networking websites may look to a centralized registration system to determine whether to display the visitor information, while still being able to obtain information about the visitor, and/or provide benefits to the visitor.

Abstract: An inhalation device to hold an inhalant-generating component to generate an inhalant to be drawn through the device and inhaled by a user. The device has a body (10) having a first open end (11b) configured to receive an inhalant-generating component and, a second open end (11a) in fluid communication with the first end through which a user may draw inhalant from the inhalant-generating component. The body is configured to receive a flavour delivery component (63) having an organoleptic material to selectively allow or prevent addition of an organoleptic additive into an inhalant stream drawn through the device. The device includes a ventilation control mechanism (15) configured to selectively allow different amounts of ambient air into the body to mix with and dilute the inhalant stream as it is drawn through the device in use.